Covestor’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-678
Closed -$35K 2852
2024
Q4
$35K Sell
678
-1,706
-72% -$83.9K 0.02% 990
2024
Q3
$99K Buy
2,384
+926
+64% +$44.5K 0.06% 522
2024
Q2
$70K Sell
1,458
-161
-10% -$7.14K 0.05% 707
2024
Q1
$78K Buy
1,619
+376
+30% +$20.1K 0.05% 683
2023
Q4
$81K Sell
1,243
-1,774
-59% -$107K 0.06% 627
2023
Q3
$197K Buy
3,017
+1,965
+187% +$124K 0.15% 113
2023
Q2
$61K Buy
1,052
+925
+728% +$58.3K 0.05% 700
2023
Q1
$8K Sell
127
-1
-0.8% -$60 0.01% 1449
2022
Q4
$8K Hold
128
0.01% 1447
2022
Q3
$9K Sell
128
-2
-2% -$149 0.01% 1323
2022
Q2
$9K Sell
130
-1
-0.8% -$72 0.01% 1271
2022
Q1
$12K Buy
131
+22
+20% +$1.8K 0.01% 1269
2021
Q4
$10K Buy
+109
New +$9.34K 0.01% 1032

Other funds holding NARI

Covestor's NARI Position: Q1 2025 in Review

Covestor sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 678 shares — an estimated $35K sold.

Covestor first reported a position in NARI in Q4 2021 and held it in 13 quarters. The position peaked at $197K in Q3 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Covestor reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Covestor sold 678 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $35K.
  • Covestor first reported a position in Inari Medical, Inc. Common Stock in Q4 2021 and held it in 13 quarters.
  • Covestor's Inari Medical, Inc. Common Stock position peaked at $197K in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Covestor's 13F filing for Q1 2025, filed 12 May 2025.